NEW YORK (GenomeWeb) – Shares of Genomic Health and Pacific Biosciences jumped significantly in November to lead a surge in stock prices for many firms in the omics tools and molecular diagnostics industries.

Overall, the GenomeWeb Index, which tracks the share prices of 31 tools and MDx firms, jumped nearly 7 percent in the month of November. The index far outpaced the performance of the Dow Jones Industrial Average (up .3 percent), the Nasdaq (up 1 percent), and the Nasdaq Biotech Index (up nearly 3 percent).